Global Candidiasis Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Candidiasis Therapeutics Market Size was estimated at USD 3118.54 million in 2023 and is projected to reach USD 3767.29 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.
This report provides a deep insight into the global Candidiasis Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Candidiasis Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Candidiasis Therapeutics market in any manner.
Global Candidiasis Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis AG
Amgen
F. Hoffmann-La Roche Ltd.
Bayer-Algeta
Merrion Pharmaceuticals Plc.
Ablynx
Genta Incorporated
Galapagos NV
Catena Pharmaceuticals Inc.
Digna Biotech S.L.
Medivir AB
Amura Holdings
Market Segmentation (by Type)
Doxorubicin
Cisplatin
7Carboplatin
Etoposide
Ifosfamide
Cyclophosphamide
Methotrexate
Vincristine
Market Segmentation (by Application)
Multispecialty Hospitals
Cancer Research Institutes
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Candidiasis Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Candidiasis Therapeutics Market Size was estimated at USD 3118.54 million in 2023 and is projected to reach USD 3767.29 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.
This report provides a deep insight into the global Candidiasis Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Candidiasis Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Candidiasis Therapeutics market in any manner.
Global Candidiasis Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis AG
Amgen
F. Hoffmann-La Roche Ltd.
Bayer-Algeta
Merrion Pharmaceuticals Plc.
Ablynx
Genta Incorporated
Galapagos NV
Catena Pharmaceuticals Inc.
Digna Biotech S.L.
Medivir AB
Amura Holdings
Market Segmentation (by Type)
Doxorubicin
Cisplatin
7Carboplatin
Etoposide
Ifosfamide
Cyclophosphamide
Methotrexate
Vincristine
Market Segmentation (by Application)
Multispecialty Hospitals
Cancer Research Institutes
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Candidiasis Therapeutics Market
- Overview of the regional outlook of the Candidiasis Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Candidiasis Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Candidiasis Therapeutics
1.2 Key Market Segments
1.2.1 Candidiasis Therapeutics Segment by Type
1.2.2 Candidiasis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANDIDIASIS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Candidiasis Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Candidiasis Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANDIDIASIS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Candidiasis Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Candidiasis Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Candidiasis Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Candidiasis Therapeutics Sales Sites, Area Served, Product Type
3.6 Candidiasis Therapeutics Market Competitive Situation and Trends
3.6.1 Candidiasis Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Candidiasis Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANDIDIASIS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Candidiasis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANDIDIASIS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Candidiasis Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Candidiasis Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Candidiasis Therapeutics Price by Type (2019-2024)
7 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Candidiasis Therapeutics Market Sales by Application (2019-2024)
7.3 Global Candidiasis Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Candidiasis Therapeutics Sales Growth Rate by Application (2019-2024)
8 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Candidiasis Therapeutics Sales by Region
8.1.1 Global Candidiasis Therapeutics Sales by Region
8.1.2 Global Candidiasis Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Candidiasis Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Candidiasis Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Candidiasis Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Candidiasis Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Candidiasis Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis AG
9.1.1 Novartis AG Candidiasis Therapeutics Basic Information
9.1.2 Novartis AG Candidiasis Therapeutics Product Overview
9.1.3 Novartis AG Candidiasis Therapeutics Product Market Performance
9.1.4 Novartis AG Business Overview
9.1.5 Novartis AG Candidiasis Therapeutics SWOT Analysis
9.1.6 Novartis AG Recent Developments
9.2 Amgen
9.2.1 Amgen Candidiasis Therapeutics Basic Information
9.2.2 Amgen Candidiasis Therapeutics Product Overview
9.2.3 Amgen Candidiasis Therapeutics Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Candidiasis Therapeutics SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Basic Information
9.3.2 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
9.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd. Business Overview
9.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.4 Bayer-Algeta
9.4.1 Bayer-Algeta Candidiasis Therapeutics Basic Information
9.4.2 Bayer-Algeta Candidiasis Therapeutics Product Overview
9.4.3 Bayer-Algeta Candidiasis Therapeutics Product Market Performance
9.4.4 Bayer-Algeta Business Overview
9.4.5 Bayer-Algeta Recent Developments
9.5 Merrion Pharmaceuticals Plc.
9.5.1 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Basic Information
9.5.2 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
9.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Market Performance
9.5.4 Merrion Pharmaceuticals Plc. Business Overview
9.5.5 Merrion Pharmaceuticals Plc. Recent Developments
9.6 Ablynx
9.6.1 Ablynx Candidiasis Therapeutics Basic Information
9.6.2 Ablynx Candidiasis Therapeutics Product Overview
9.6.3 Ablynx Candidiasis Therapeutics Product Market Performance
9.6.4 Ablynx Business Overview
9.6.5 Ablynx Recent Developments
9.7 Genta Incorporated
9.7.1 Genta Incorporated Candidiasis Therapeutics Basic Information
9.7.2 Genta Incorporated Candidiasis Therapeutics Product Overview
9.7.3 Genta Incorporated Candidiasis Therapeutics Product Market Performance
9.7.4 Genta Incorporated Business Overview
9.7.5 Genta Incorporated Recent Developments
9.8 Galapagos NV
9.8.1 Galapagos NV Candidiasis Therapeutics Basic Information
9.8.2 Galapagos NV Candidiasis Therapeutics Product Overview
9.8.3 Galapagos NV Candidiasis Therapeutics Product Market Performance
9.8.4 Galapagos NV Business Overview
9.8.5 Galapagos NV Recent Developments
9.9 Catena Pharmaceuticals Inc.
9.9.1 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Basic Information
9.9.2 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
9.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Market Performance
9.9.4 Catena Pharmaceuticals Inc. Business Overview
9.9.5 Catena Pharmaceuticals Inc. Recent Developments
9.10 Digna Biotech S.L.
9.10.1 Digna Biotech S.L. Candidiasis Therapeutics Basic Information
9.10.2 Digna Biotech S.L. Candidiasis Therapeutics Product Overview
9.10.3 Digna Biotech S.L. Candidiasis Therapeutics Product Market Performance
9.10.4 Digna Biotech S.L. Business Overview
9.10.5 Digna Biotech S.L. Recent Developments
9.11 Medivir AB
9.11.1 Medivir AB Candidiasis Therapeutics Basic Information
9.11.2 Medivir AB Candidiasis Therapeutics Product Overview
9.11.3 Medivir AB Candidiasis Therapeutics Product Market Performance
9.11.4 Medivir AB Business Overview
9.11.5 Medivir AB Recent Developments
9.12 Amura Holdings
9.12.1 Amura Holdings Candidiasis Therapeutics Basic Information
9.12.2 Amura Holdings Candidiasis Therapeutics Product Overview
9.12.3 Amura Holdings Candidiasis Therapeutics Product Market Performance
9.12.4 Amura Holdings Business Overview
9.12.5 Amura Holdings Recent Developments
10 CANDIDIASIS THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Candidiasis Therapeutics Market Size Forecast
10.2 Global Candidiasis Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Candidiasis Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region
10.2.4 South America Candidiasis Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Candidiasis Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Candidiasis Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Candidiasis Therapeutics by Type (2025-2030)
11.1.2 Global Candidiasis Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Candidiasis Therapeutics by Type (2025-2030)
11.2 Global Candidiasis Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Candidiasis Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Candidiasis Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Candidiasis Therapeutics
1.2 Key Market Segments
1.2.1 Candidiasis Therapeutics Segment by Type
1.2.2 Candidiasis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANDIDIASIS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Candidiasis Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Candidiasis Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANDIDIASIS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Candidiasis Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Candidiasis Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Candidiasis Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Candidiasis Therapeutics Sales Sites, Area Served, Product Type
3.6 Candidiasis Therapeutics Market Competitive Situation and Trends
3.6.1 Candidiasis Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Candidiasis Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANDIDIASIS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Candidiasis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANDIDIASIS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Candidiasis Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Candidiasis Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Candidiasis Therapeutics Price by Type (2019-2024)
7 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Candidiasis Therapeutics Market Sales by Application (2019-2024)
7.3 Global Candidiasis Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Candidiasis Therapeutics Sales Growth Rate by Application (2019-2024)
8 CANDIDIASIS THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Candidiasis Therapeutics Sales by Region
8.1.1 Global Candidiasis Therapeutics Sales by Region
8.1.2 Global Candidiasis Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Candidiasis Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Candidiasis Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Candidiasis Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Candidiasis Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Candidiasis Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis AG
9.1.1 Novartis AG Candidiasis Therapeutics Basic Information
9.1.2 Novartis AG Candidiasis Therapeutics Product Overview
9.1.3 Novartis AG Candidiasis Therapeutics Product Market Performance
9.1.4 Novartis AG Business Overview
9.1.5 Novartis AG Candidiasis Therapeutics SWOT Analysis
9.1.6 Novartis AG Recent Developments
9.2 Amgen
9.2.1 Amgen Candidiasis Therapeutics Basic Information
9.2.2 Amgen Candidiasis Therapeutics Product Overview
9.2.3 Amgen Candidiasis Therapeutics Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Candidiasis Therapeutics SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Basic Information
9.3.2 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
9.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd. Business Overview
9.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.4 Bayer-Algeta
9.4.1 Bayer-Algeta Candidiasis Therapeutics Basic Information
9.4.2 Bayer-Algeta Candidiasis Therapeutics Product Overview
9.4.3 Bayer-Algeta Candidiasis Therapeutics Product Market Performance
9.4.4 Bayer-Algeta Business Overview
9.4.5 Bayer-Algeta Recent Developments
9.5 Merrion Pharmaceuticals Plc.
9.5.1 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Basic Information
9.5.2 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
9.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Market Performance
9.5.4 Merrion Pharmaceuticals Plc. Business Overview
9.5.5 Merrion Pharmaceuticals Plc. Recent Developments
9.6 Ablynx
9.6.1 Ablynx Candidiasis Therapeutics Basic Information
9.6.2 Ablynx Candidiasis Therapeutics Product Overview
9.6.3 Ablynx Candidiasis Therapeutics Product Market Performance
9.6.4 Ablynx Business Overview
9.6.5 Ablynx Recent Developments
9.7 Genta Incorporated
9.7.1 Genta Incorporated Candidiasis Therapeutics Basic Information
9.7.2 Genta Incorporated Candidiasis Therapeutics Product Overview
9.7.3 Genta Incorporated Candidiasis Therapeutics Product Market Performance
9.7.4 Genta Incorporated Business Overview
9.7.5 Genta Incorporated Recent Developments
9.8 Galapagos NV
9.8.1 Galapagos NV Candidiasis Therapeutics Basic Information
9.8.2 Galapagos NV Candidiasis Therapeutics Product Overview
9.8.3 Galapagos NV Candidiasis Therapeutics Product Market Performance
9.8.4 Galapagos NV Business Overview
9.8.5 Galapagos NV Recent Developments
9.9 Catena Pharmaceuticals Inc.
9.9.1 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Basic Information
9.9.2 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
9.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Market Performance
9.9.4 Catena Pharmaceuticals Inc. Business Overview
9.9.5 Catena Pharmaceuticals Inc. Recent Developments
9.10 Digna Biotech S.L.
9.10.1 Digna Biotech S.L. Candidiasis Therapeutics Basic Information
9.10.2 Digna Biotech S.L. Candidiasis Therapeutics Product Overview
9.10.3 Digna Biotech S.L. Candidiasis Therapeutics Product Market Performance
9.10.4 Digna Biotech S.L. Business Overview
9.10.5 Digna Biotech S.L. Recent Developments
9.11 Medivir AB
9.11.1 Medivir AB Candidiasis Therapeutics Basic Information
9.11.2 Medivir AB Candidiasis Therapeutics Product Overview
9.11.3 Medivir AB Candidiasis Therapeutics Product Market Performance
9.11.4 Medivir AB Business Overview
9.11.5 Medivir AB Recent Developments
9.12 Amura Holdings
9.12.1 Amura Holdings Candidiasis Therapeutics Basic Information
9.12.2 Amura Holdings Candidiasis Therapeutics Product Overview
9.12.3 Amura Holdings Candidiasis Therapeutics Product Market Performance
9.12.4 Amura Holdings Business Overview
9.12.5 Amura Holdings Recent Developments
10 CANDIDIASIS THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Candidiasis Therapeutics Market Size Forecast
10.2 Global Candidiasis Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Candidiasis Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region
10.2.4 South America Candidiasis Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Candidiasis Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Candidiasis Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Candidiasis Therapeutics by Type (2025-2030)
11.1.2 Global Candidiasis Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Candidiasis Therapeutics by Type (2025-2030)
11.2 Global Candidiasis Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Candidiasis Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Candidiasis Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Candidiasis Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Candidiasis Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Candidiasis Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Candidiasis Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Therapeutics as of 2022)
Table 10. Global Market Candidiasis Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Candidiasis Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Candidiasis Therapeutics Product Type
Table 13. Global Candidiasis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Candidiasis Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Candidiasis Therapeutics Market Challenges
Table 22. Global Candidiasis Therapeutics Sales by Type (Kilotons)
Table 23. Global Candidiasis Therapeutics Market Size by Type (M USD)
Table 24. Global Candidiasis Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Candidiasis Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Candidiasis Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Candidiasis Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Candidiasis Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Candidiasis Therapeutics Sales (Kilotons) by Application
Table 30. Global Candidiasis Therapeutics Market Size by Application
Table 31. Global Candidiasis Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Candidiasis Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Candidiasis Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Candidiasis Therapeutics Market Share by Application (2019-2024)
Table 35. Global Candidiasis Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Candidiasis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Candidiasis Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Candidiasis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Candidiasis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Candidiasis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Candidiasis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Candidiasis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis AG Candidiasis Therapeutics Basic Information
Table 44. Novartis AG Candidiasis Therapeutics Product Overview
Table 45. Novartis AG Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis AG Business Overview
Table 47. Novartis AG Candidiasis Therapeutics SWOT Analysis
Table 48. Novartis AG Recent Developments
Table 49. Amgen Candidiasis Therapeutics Basic Information
Table 50. Amgen Candidiasis Therapeutics Product Overview
Table 51. Amgen Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Candidiasis Therapeutics SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Basic Information
Table 56. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
Table 57. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics SWOT Analysis
Table 59. F. Hoffmann-La Roche Ltd. Business Overview
Table 60. F. Hoffmann-La Roche Ltd. Recent Developments
Table 61. Bayer-Algeta Candidiasis Therapeutics Basic Information
Table 62. Bayer-Algeta Candidiasis Therapeutics Product Overview
Table 63. Bayer-Algeta Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bayer-Algeta Business Overview
Table 65. Bayer-Algeta Recent Developments
Table 66. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Basic Information
Table 67. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
Table 68. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merrion Pharmaceuticals Plc. Business Overview
Table 70. Merrion Pharmaceuticals Plc. Recent Developments
Table 71. Ablynx Candidiasis Therapeutics Basic Information
Table 72. Ablynx Candidiasis Therapeutics Product Overview
Table 73. Ablynx Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Ablynx Business Overview
Table 75. Ablynx Recent Developments
Table 76. Genta Incorporated Candidiasis Therapeutics Basic Information
Table 77. Genta Incorporated Candidiasis Therapeutics Product Overview
Table 78. Genta Incorporated Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Genta Incorporated Business Overview
Table 80. Genta Incorporated Recent Developments
Table 81. Galapagos NV Candidiasis Therapeutics Basic Information
Table 82. Galapagos NV Candidiasis Therapeutics Product Overview
Table 83. Galapagos NV Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Galapagos NV Business Overview
Table 85. Galapagos NV Recent Developments
Table 86. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Basic Information
Table 87. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
Table 88. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Catena Pharmaceuticals Inc. Business Overview
Table 90. Catena Pharmaceuticals Inc. Recent Developments
Table 91. Digna Biotech S.L. Candidiasis Therapeutics Basic Information
Table 92. Digna Biotech S.L. Candidiasis Therapeutics Product Overview
Table 93. Digna Biotech S.L. Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Digna Biotech S.L. Business Overview
Table 95. Digna Biotech S.L. Recent Developments
Table 96. Medivir AB Candidiasis Therapeutics Basic Information
Table 97. Medivir AB Candidiasis Therapeutics Product Overview
Table 98. Medivir AB Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Medivir AB Business Overview
Table 100. Medivir AB Recent Developments
Table 101. Amura Holdings Candidiasis Therapeutics Basic Information
Table 102. Amura Holdings Candidiasis Therapeutics Product Overview
Table 103. Amura Holdings Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Amura Holdings Business Overview
Table 105. Amura Holdings Recent Developments
Table 106. Global Candidiasis Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Candidiasis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Candidiasis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Candidiasis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Candidiasis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Candidiasis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Candidiasis Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Candidiasis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Candidiasis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Candidiasis Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Candidiasis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Candidiasis Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Candidiasis Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Candidiasis Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Candidiasis Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Candidiasis Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Candidiasis Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Candidiasis Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Candidiasis Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Candidiasis Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Candidiasis Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candidiasis Therapeutics as of 2022)
Table 10. Global Market Candidiasis Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Candidiasis Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Candidiasis Therapeutics Product Type
Table 13. Global Candidiasis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Candidiasis Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Candidiasis Therapeutics Market Challenges
Table 22. Global Candidiasis Therapeutics Sales by Type (Kilotons)
Table 23. Global Candidiasis Therapeutics Market Size by Type (M USD)
Table 24. Global Candidiasis Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Candidiasis Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Candidiasis Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Candidiasis Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Candidiasis Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Candidiasis Therapeutics Sales (Kilotons) by Application
Table 30. Global Candidiasis Therapeutics Market Size by Application
Table 31. Global Candidiasis Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Candidiasis Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Candidiasis Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Candidiasis Therapeutics Market Share by Application (2019-2024)
Table 35. Global Candidiasis Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Candidiasis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Candidiasis Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Candidiasis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Candidiasis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Candidiasis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Candidiasis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Candidiasis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis AG Candidiasis Therapeutics Basic Information
Table 44. Novartis AG Candidiasis Therapeutics Product Overview
Table 45. Novartis AG Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis AG Business Overview
Table 47. Novartis AG Candidiasis Therapeutics SWOT Analysis
Table 48. Novartis AG Recent Developments
Table 49. Amgen Candidiasis Therapeutics Basic Information
Table 50. Amgen Candidiasis Therapeutics Product Overview
Table 51. Amgen Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Candidiasis Therapeutics SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Basic Information
Table 56. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product Overview
Table 57. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics SWOT Analysis
Table 59. F. Hoffmann-La Roche Ltd. Business Overview
Table 60. F. Hoffmann-La Roche Ltd. Recent Developments
Table 61. Bayer-Algeta Candidiasis Therapeutics Basic Information
Table 62. Bayer-Algeta Candidiasis Therapeutics Product Overview
Table 63. Bayer-Algeta Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bayer-Algeta Business Overview
Table 65. Bayer-Algeta Recent Developments
Table 66. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Basic Information
Table 67. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product Overview
Table 68. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merrion Pharmaceuticals Plc. Business Overview
Table 70. Merrion Pharmaceuticals Plc. Recent Developments
Table 71. Ablynx Candidiasis Therapeutics Basic Information
Table 72. Ablynx Candidiasis Therapeutics Product Overview
Table 73. Ablynx Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Ablynx Business Overview
Table 75. Ablynx Recent Developments
Table 76. Genta Incorporated Candidiasis Therapeutics Basic Information
Table 77. Genta Incorporated Candidiasis Therapeutics Product Overview
Table 78. Genta Incorporated Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Genta Incorporated Business Overview
Table 80. Genta Incorporated Recent Developments
Table 81. Galapagos NV Candidiasis Therapeutics Basic Information
Table 82. Galapagos NV Candidiasis Therapeutics Product Overview
Table 83. Galapagos NV Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Galapagos NV Business Overview
Table 85. Galapagos NV Recent Developments
Table 86. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Basic Information
Table 87. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product Overview
Table 88. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Catena Pharmaceuticals Inc. Business Overview
Table 90. Catena Pharmaceuticals Inc. Recent Developments
Table 91. Digna Biotech S.L. Candidiasis Therapeutics Basic Information
Table 92. Digna Biotech S.L. Candidiasis Therapeutics Product Overview
Table 93. Digna Biotech S.L. Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Digna Biotech S.L. Business Overview
Table 95. Digna Biotech S.L. Recent Developments
Table 96. Medivir AB Candidiasis Therapeutics Basic Information
Table 97. Medivir AB Candidiasis Therapeutics Product Overview
Table 98. Medivir AB Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Medivir AB Business Overview
Table 100. Medivir AB Recent Developments
Table 101. Amura Holdings Candidiasis Therapeutics Basic Information
Table 102. Amura Holdings Candidiasis Therapeutics Product Overview
Table 103. Amura Holdings Candidiasis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Amura Holdings Business Overview
Table 105. Amura Holdings Recent Developments
Table 106. Global Candidiasis Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Candidiasis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Candidiasis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Candidiasis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Candidiasis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Candidiasis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Candidiasis Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Candidiasis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Candidiasis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Candidiasis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Candidiasis Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Candidiasis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Candidiasis Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Candidiasis Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Candidiasis Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Candidiasis Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Candidiasis Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Candidiasis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Candidiasis Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Candidiasis Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Candidiasis Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Candidiasis Therapeutics Market Size by Country (M USD)
Figure 11. Candidiasis Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Candidiasis Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Candidiasis Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Candidiasis Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Candidiasis Therapeutics Market Share by Type
Figure 18. Sales Market Share of Candidiasis Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Candidiasis Therapeutics by Type in 2023
Figure 20. Market Size Share of Candidiasis Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Candidiasis Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Candidiasis Therapeutics Market Share by Application
Figure 24. Global Candidiasis Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Candidiasis Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Candidiasis Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Candidiasis Therapeutics Market Share by Application in 2023
Figure 28. Global Candidiasis Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Candidiasis Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Candidiasis Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Candidiasis Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Candidiasis Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Candidiasis Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Candidiasis Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Candidiasis Therapeutics Sales Market Share by Region in 2023
Figure 44. China Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Candidiasis Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Candidiasis Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Candidiasis Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Candidiasis Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Candidiasis Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Candidiasis Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Candidiasis Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Candidiasis Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Candidiasis Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Candidiasis Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Candidiasis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Candidiasis Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Candidiasis Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Candidiasis Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Candidiasis Therapeutics Market Size by Country (M USD)
Figure 11. Candidiasis Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Candidiasis Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Candidiasis Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Candidiasis Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Candidiasis Therapeutics Market Share by Type
Figure 18. Sales Market Share of Candidiasis Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Candidiasis Therapeutics by Type in 2023
Figure 20. Market Size Share of Candidiasis Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Candidiasis Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Candidiasis Therapeutics Market Share by Application
Figure 24. Global Candidiasis Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Candidiasis Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Candidiasis Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Candidiasis Therapeutics Market Share by Application in 2023
Figure 28. Global Candidiasis Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Candidiasis Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Candidiasis Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Candidiasis Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Candidiasis Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Candidiasis Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Candidiasis Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Candidiasis Therapeutics Sales Market Share by Region in 2023
Figure 44. China Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Candidiasis Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Candidiasis Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Candidiasis Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Candidiasis Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Candidiasis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Candidiasis Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Candidiasis Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Candidiasis Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Candidiasis Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Candidiasis Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Candidiasis Therapeutics Market Share Forecast by Application (2025-2030)
